subject: Savient Pharmaceuticals Inc - Swot Analysis - Market Research Reports On Aarkstore Enterprise [print this page] Savient Pharmaceuticals Inc - SWOT Analysis company profile is the essential source for top-level company data and information. Savient Pharmaceuticals Inc - SWOT Analysis examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Savient Pharmaceuticals (Savient) is a specialty biopharmaceutical company engaged in developing Krystexxa (pegloticase) for the treatment of chronic gout in patients refractory to conventional therapy. It also manufactures and supplies Oxandrin (oxandrolone tablets, USP) CIII in the US. The company primarily operates in the US. It is headquartered in East Brunswick, New Jersey and employed 43 people as of February 01, 2010. The company recorded revenues of $3 million during the financial year (FY) ended December 2009, a decrease of 6.9% over FY2008. The operating loss of the company was $81.2 million during FY2009, as compared to an operating loss of $89 million in FY2008. The net loss was $90.9 million in FY2009, as compared with a net loss of $84.2 million in FY2008.
Scope of the Report
- Provides all the crucial information on Savient Pharmaceuticals Inc required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Savient Pharmaceuticals Inc in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Savient Pharmaceuticals Inc
-Data is supplemented with details on Savient Pharmaceuticals Inc history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Savient Pharmaceuticals Inc
Reasons to Purchase
- Support sales activities by understanding your customers businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors business structure, strategy and prospects
- Obtain the most up to date company information available
